causal

Antibiotic development underinvested due to weak incentives

The coronavirus pandemic reflects under-investment in infectious disease prevention, monitoring and pharmaceuticals, partly because the economic incentives for entrepreneurs to develop new antibiotics or anti-infectives are lacking.

causalpending

Speaker

D.A.

Evidence Quote

“Part of that results from the lack of incentives for entrepreneurs to develop new types of antibiotics or anti-infectives.”

Source

Investing in Healthcare— Invest Like the Best
Created: 11/17/2026, 5:03:43 PM

Your notes

Loading notes...